DLJ14, a novel chemo-sensitization agent, enhances therapeutic effects of adriamycin against MCF-7/A cells both in vitro and in vivo
Hits:
Institution:药学院
Title of Paper: DLJ14, a novel chemo-sensitization agent, enhances therapeutic effects of adriamycin against MCF-7/A cells both in vitro and in vivo
Journal:J Pharmacy Pharmacology
First Author:郭秀丽
All the Authors:刘新泳
Document Code:lw-158882
Volume:66
Issue:3
Page Number:398
Translation or Not:No
Date of Publication:2014-03
Release Time:2019-04-14
Prev One:A tetramethylpyrazine piperazine derivate CXC137 prevents cell injury in SH-SY5Y cells and improves memory dysfunction of rats with vascular dementia
Next One: Design, synthesis and acetylcholinesterase (AChE) inhibition assay of novel 9-(1-(substituted-benzyl) piperidin-4-yl)-2-chloro-9H-purin-6-amine derivatives.